Chimerix Inc. buy BiotechBee
Start price
24.06.23
/
50%
€1.19
Target price
31.03.26
€3.00
Performance (%)
132.10%
End price
14.12.24
€2.76
Summary
This prediction ended on 14.12.24 with a price of €2.76. With a performance of 132.10% the BUY prediction by BiotechBee was a big success. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chimerix Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
According to BiotechBee what are the pros and cons of Chimerix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year